Status:
RECRUITING
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Neuro-Ophthalmology
Eligibility:
All Genders
18+ years
Brief Summary
The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences...
Eligibility Criteria
Inclusion
- Patient over 18 years old
- Patient with suspected NOIA, evoked after clinical examination by a specialized ophthalmologist
- For which a brain and visual MRI is planned
- Express consent to participate in the study
- Affiliate or beneficiary of a Social Security scheme
Exclusion
- Contraindication to MRI (electrical device, metallic foreign body, claustrophobia)
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
October 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04451265
Start Date
October 26 2022
End Date
March 1 2028
Last Update
January 5 2026
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de LILLE
Lille, Lille, France, 59000
2
Fondation A De Rothschild
Paris, PARIS, France, 75019
3
Chu Rouen
Rouen, France, 76100